Smruthi Organics Ltd
BSE:540686

Watchlist Manager
Smruthi Organics Ltd Logo
Smruthi Organics Ltd
BSE:540686
Watchlist
Price: 116 INR -1.19% Market Closed
Market Cap: ₹1.3B

Net Margin

3.9%
Current
Improving
by 1.3%
vs 3-y average of 2.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.9%
=
Net Income
₹46.7m
/
Revenue
₹1.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
3.9%
=
Net Income
₹46.7m
/
Revenue
₹1.2B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Smruthi Organics Ltd
BSE:540686
1.4B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

In line with most companies in India
Percentile
40th
Based on 5 531 companies
40th percentile
3.9%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Smruthi Organics Ltd
Glance View

Market Cap
1.3B INR
Industry
Pharmaceuticals

Smruthi Organics Ltd. engages in the manufacture and sale of bulk drugs and drug intermediates. The company is headquartered in Solapur, Maharashtra. The company went IPO on 2017-08-29. The Company’s operating segments include Formulation. The firm's products include AMLODIPINE BESILATE, AMISULPRIDE, CARBIDOPA, CIPROFLOXACIN, DILOXANIDE FUROATE, FENOFIBRATE, METFORMIN HYDROCHLORIDE, NORFLOXACIN, PEFLOXACIN, TELMISARTAN, AMLODIPINE BASE and PHTHALOYL AMLODIPINE. The firm has 2 manufacturing facilities in Solapur, Maharashtra. with a combined reactor capacity of over 320 kiloliters. The firm manufactures API from kilo to metric ton scale. The firm serves pharmaceutical companies in India and across the globe. The firm caters to both domestic and international markets.

SMRUTHIORG Intrinsic Value
251.23 INR
Undervaluation 54%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
3.9%
=
Net Income
₹46.7m
/
Revenue
₹1.2B
What is Smruthi Organics Ltd's current Net Margin?

The current Net Margin for Smruthi Organics Ltd is 3.9%, which is above its 3-year median of 2.6%.

How has Net Margin changed over time?

Over the last 3 years, Smruthi Organics Ltd’s Net Margin has decreased from 5.8% to 3.9%. During this period, it reached a low of -0.8% on Sep 30, 2024 and a high of 5.8% on Sep 30, 2022.

Back to Top